Società Nemaura Medical Inc OTC Bulletin Board
Azioni
US6404421090
Fornitura medica
Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Continuous Glucose Monitoring System
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -84,71% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -84,71% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Dewan Chowdhury
CEO | Chief Executive Officer | 50 | 24/12/13 |
Arash Ghadar
COO | Chief Operating Officer | 47 | 05/01/22 |
Richard Toon
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
Samantha Sanders
PRN | Corporate Officer/Principal | - | 15/04/21 |
David Scott
PRN | Corporate Officer/Principal | - | - |
Jay L. Warner
PRN | Corporate Officer/Principal | - | 01/02/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Dewan Chowdhury
CEO | Chief Executive Officer | 50 | 24/12/13 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 40 351 702 | 17 255 392 ( 42,76 %) | 0 | 42,76 % |
Coordinate società
Nemaura Medical, Inc.
57 West 57th Street Manhattan
10019, New York
+646 416 8000
http://www.nemauramedical.com![Indirizzo Nemaura Medical Inc](https://cdn.zonebourse.com/static/address/18445426.png)
Società del gruppo
Nome | Categoria e settore |
---|---|
Dermal Diagnostics Ltd.
![]() Dermal Diagnostics Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Nemaura Medical, Inc., Dermal Diagnostics Ltd. is a British company that provides research and experimental development services on natural sciences and engineering. The company is based in Loughborough, UK. The CEO of the company is Dewan Fazlul Hoque Chowdhury. |
Miscellaneous Commercial Services
|
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
-5,31% | 181 Mrd | |
-5,38% | 99,95 Mrd | |
-6,04% | 66,21 Mrd | |
+16,45% | 45,4 Mrd | |
-8,08% | 45,36 Mrd | |
+8,38% | 43,84 Mrd | |
+12,06% | 29,03 Mrd | |
+17,98% | 25,64 Mrd | |
-8,28% | 23,53 Mrd |